Last: | $24.18 |
---|---|
Change Percent: | -0.04% |
Open: | $24.14 |
Close: | $24.19 |
High: | $24.3 |
Low: | $24.09 |
Volume: | 70,479 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$24.18 | $24.14 | $24.19 | $24.3 | $24.09 | 70,479 | 07-17-2024 |
$24.19 | $23.94 | $24.19 | $24.23 | $23.9254 | 184,531 | 07-16-2024 |
$23.88 | $23.86 | $23.88 | $23.98 | $23.7601 | 121,935 | 07-15-2024 |
$23.78 | $23.72 | $23.78 | $23.92 | $23.72 | 76,147 | 07-12-2024 |
$23.56 | $23.53 | $23.56 | $23.75 | $23.483 | 162,287 | 07-11-2024 |
$23.46 | $23.44 | $23.46 | $23.47 | $23.37 | 95,354 | 07-10-2024 |
$23.32 | $23.47 | $23.32 | $23.51 | $23.32 | 96,415 | 07-09-2024 |
$23.36 | $23.48 | $23.36 | $23.57 | $23.34 | 118,123 | 07-08-2024 |
$23.47 | $23.52 | $23.47 | $23.5699 | $23.349 | 79,981 | 07-05-2024 |
$23.52 | $23.41 | $23.52 | $23.57 | $23.41 | 78,829 | 07-04-2024 |
$23.52 | $23.41 | $23.52 | $23.57 | $23.41 | 78,829 | 07-03-2024 |
$23.4 | $23.26 | $23.4 | $23.4 | $23.22 | 106,389 | 07-02-2024 |
$23.22 | $23.4 | $23.22 | $23.54 | $23.21 | 107,651 | 07-01-2024 |
$23.29 | $23.43 | $23.29 | $23.54 | $23.25 | 140,113 | 06-28-2024 |
$23.23 | $23.2 | $23.23 | $23.37 | $23.1201 | 105,853 | 06-27-2024 |
$23.1 | $23.16 | $23.1 | $23.225 | $23 | 89,306 | 06-26-2024 |
$23.26 | $23.32 | $23.26 | $23.335 | $23.23 | 83,021 | 06-25-2024 |
$23.21 | $23.08 | $23.21 | $23.33 | $23.07 | 60,235 | 06-24-2024 |
$23 | $23.06 | $23 | $23.1285 | $22.91 | 103,900 | 06-21-2024 |
$22.9854 | $23.0748 | $22.9854 | $23.1343 | $22.9457 | 108,524 | 06-20-2024 |
News, Short Squeeze, Breakout and More Instantly...
Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest Company Name:
EVT Stock Symbol:
NYSE Market:
Multi-year collaboration will initially focus on early discovery research for metabolic and infectious diseases HAMBURG, GERMANY / ACCESSWIRE / July 10, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(NASDAQ:EVO) (MDAX/TecDAX , ISIN: DE0005664809) today announced it has entered into a mul...
Just - Evotec Biologics expands partnership with Sandoz for development and commercial manufacturing of biosimilars Additional biosimilars potentially to be added to Sandoz development pipeline Further guarantees for Sandoz long-term commercial supply security HAMBURG, GERMANY...
Just - Evotec Biologics will deliver an ultra-rapid, cost-efficient biotherapeutics manufacturing platform solution for the DOD's Manufacturing Optimization Program Manufacturing solution includes seamless integration of accelerated mAb drug development into the overall Manufacturing Optimiz...